Clinical Trial Update: Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a computerized olfactory training program for cognitive decline in early Alzheimer's disease and mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Evon Medics LLC | Conditions: Mild Cognitive Impairment, Early Alzheimer's Disease | Phase 2 | Status: UNKNOWN